Skip to content

Dental sensitivity toothpastes: a clinical safety and effectiveness investigation conducted on healthy adult participants.

Double-Blind, three-Arm, randomized, intervention, prospective, in-use tolerability, clinical safety and efficacy study of teeth sensitivity toothpastes in healthy adult subjects: dentine hypersensitivity testing - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/071115
Enrollment
105
Registered
2024-07-23
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K089- Disorder of teeth and supporting structures, unspecified

Interventions

Intervention1: Test Treatment A - Dentine Hypersensitivity Toothpaste: Apply a pea-sized amount of toothpaste on the toothbrush bristles. Angle the toothbrush at 45 degrees to your gums and gently mo

Sponsors

Dabur India Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Age will be 18 to 65 years (both inclusive) old at the time of consent. 2)Sex will be Healthy adult males and non-pregnant/non-lactating females. 3)Females of childbearing potential have a self-reported negative urine pregnancy test at the time of the screening visit and agree to follow an accepted method of birth control for the duration of the study such as condoms, foams, jellies, diaphragm, intrauterine device etc. 4)Subjects are generally in good general health as determined from recent medical history. 5)Subjects with a plaque index and gingivitis index score greater than 1 during screening. 6)Subjects having hypersensitive tooth during screening. 7)Subjects having root caries at time of screening. 8)Subjects having 6 present upper front teeth. 9)Anterior teeth without restorations. 10)No previous treatments performed on tooth. 11)Subjects who agree to discontinue the use of over-the-counter any teeth products throughout the trial. 12)Subjects who agree to refrain from the use of any oral products that may cause staining (chlorhexidine rinses, stannous fluoride toothpaste, etc.). 13)Agree not to participate in any other oral/dental product studies during the trial. 14)Agree to return for all scheduled visits and follow study procedures. 15)Subjects who are willing to complete all study procedures including study-related questionnaires and comply with study requirements.

Exclusion criteria

Exclusion criteria: 1)Subjects who are undergoing treatment for gingivitis, caries, dental plaque and sensitivity. 2)Subjects are present with fixed orthodontic appliances on the facial surfaces of the maxillary arch. 3)Subjects have dental crowns, veneers or composite restorations on gradable maxillary anterior teeth (canine to canine) or mandibular anterior teeth. 4)Subjects have any oral pathologies or gross neglect of home care requiring prompt treatment, including periodontal disease, as evidenced by purulent exudate, exposed root surfaces (generalized recession), tooth mobility, and/or other signs indicating that the integrity of the data collected for that subject might be compromised. 5)Subjects are present with any pre-existing oral or medical condition that the Investigator/designee determines may place the subject at increased health risk from study participation. 6)Subjects have meaningful malocclusion that would impact treatment or ease of viewing/scoring anterior teeth. 7)Subjects have teeth with severe or atypical intrinsic staining, such as that caused by tetracycline, fluorosis or hypo calcification. 8)Subjects have any known allergies to over-the-counter oral hygiene/ products. 9)Subjects have any known allergies to the trial product ingredients. 10)The subject must have participated in a clinical study with oral care or oral hygiene within 4 weeks before the screening visit of this study. 11)Any other condition which could warrant exclusion from the study, as per the investigator’s discretion. 12) Subjects who smoke and are pan eaters. 13) Subjects with hypersensitive teeth and with mobility greater than one as per miller tooth mobility index. 14) Subjects having chipped teeth and defective restorations. 15) Subjects having deep periodontal pockets. 16) Subjects having bridgework in their teeth and dentures which interrupt during evaluation. 17) Subjects undergoing periodontal surgery within previous 6 months. 18) Subjects undergoing treatment with antibiotics, anti-inflammatory, anticonvulsants, anti histaminic, anti-depressant, anti-histaminic, sedatives, tranquilizers or daily analgesic drugs. 19) Subjects having uncontrolled metabolic disease. 20) Subjects overexposure to acidic by dietary and environment exposure.

Design outcomes

Primary

MeasureTime frame
1.To evaluate the effectiveness of the test treatments in terms of change in plaque deposition with regular use of test treatments. (Digital photographs of stained teeth will be taken) 2.To evaluate the effectiveness of the test treatments in terms of change in plaque induced gingivitis with regular use of test treatments. 3.To evaluate the effectiveness of the test treatments in terms of change in root caries with regular use of test treatments. 4.To evaluate the effectiveness of the test treatments in terms of change in teeth sensitivity assessed by techniques like air-blast, cold thermal stimuli and 20% acid solution (lemon solution) with regular use of test treatments. Timepoint: Baseline before usage of the test treatments and after usage of test treatments at T1 min, T30 mins on Day 01, before usage of the test treatments and after usage of test treatments at T1 min, T30 mins on Day 30 , before usage of the test treatments and after usage of test treatments at T1 min, T30 mins on Day 60 and on Day 61 before brushing at morning

Secondary

MeasureTime frame
1. To assess the effectiveness of the test treatments in terms of subject treatment perception questionnaire.Timepoint: Baseline before usage of the test treatments and after usage of test treatments at T1 min, T30 mins on Day 01, before usage of the test treatments and after usage of test treatments at T1 min, T30 mins on Day 30 , before usage of the test treatments and after usage of test treatments at T1 min, T30 mins on Day 60 and on Day 61 before brushing at morning

Countries

India

Contacts

Public ContactMaheshvari Patel

NovoBliss Research Private Limited

dr.nayan@novobliss.in9909013286

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026